{
  "company": {
    "name": "Innoventric",
    "website": "https://innoventric.com/",
    "record": "https://startuphistory.org/c/innoventric.com"
  },
  "status": null,
  "history_since": "2020-12-01T20:20:07.000Z",
  "baseline": {
    "snapshot_id": "9f0bd6e8a00ce42ca40d8a61f12f6c567eb3bfcb546f0734877110c71034d507",
    "observed_at": "2020-12-01T20:20:07.000Z",
    "headline": "A SIMPLE, SAFE, RELIABLE TRANSCATHETER SOLUTION FOR TRICUSPID REGURGITION",
    "description": "nnoventric is dedicated to the development sophisticated transcatheter solutions for patients with severe heart diseases",
    "evidence": "https://web.archive.org/web/20201201202007/https://www.innoventric.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:24:20.950Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2024-01-27T10:18:19.000Z",
      "variants": [
        {
          "headline": "A SIMPLE, SAFE, RELIABLE TRANSCATHETER SOLUTION FOR TRICUSPID REGURGITION",
          "subhead": "nnoventric is dedicated to the development sophisticated transcatheter solutions for patients with severe heart diseases",
          "observed_at": "2020-12-01T20:20:07.000Z",
          "evidence": "https://web.archive.org/web/20201201202007/https://www.innoventric.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "A SIMPLE, SAFE, RELIABLE TRANSCATHETER SOLUTION FOR TRICUSPID REGURGITION",
          "subhead": "nnoventric is dedicated to the development sophisticated transcatheter solutions for patients with severe heart diseases",
          "observed_at": "2022-01-05T16:03:02.000Z",
          "evidence": "https://web.archive.org/web/20220105160302/https://www.innoventric.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "A SIMPLE, SAFE, RELIABLE TRANSCATHETER SOLUTION FOR TRICUSPID REGURGITION",
          "subhead": "nnoventric is dedicated to the development sophisticated transcatheter solutions for patients with severe heart diseases",
          "observed_at": "2022-08-11T13:59:19.000Z",
          "evidence": "https://web.archive.org/web/20220811135919/https://www.innoventric.com",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "A SIMPLE, SAFE, RELIABLE TRANSCATHETER SOLUTION FOR TRICUSPID REGURGITATION",
          "subhead": "nnoventric is dedicated to the development sophisticated transcatheter solutions for patients with severe heart diseases",
          "observed_at": "2023-09-26T09:30:38.000Z",
          "evidence": "https://web.archive.org/web/20230926093038/https://www.innoventric.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "A SIMPLE, SAFE, RELIABLE TRANSCATHETER SOLUTION FOR TRICUSPID REGURGITATION",
          "subhead": "nnoventric is dedicated to the development sophisticated transcatheter solutions for patients with severe heart diseases",
          "observed_at": "2024-01-27T10:18:19.000Z",
          "evidence": "https://web.archive.org/web/20240127101819/https://www.innoventric.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "A SIMPLE, SAFE, RELIABLE TRANSCATHETER SOLUTION FOR TRICUSPID REGURGITATION",
      "subhead": "nnoventric is dedicated to the development sophisticated transcatheter solutions for patients with severe heart diseases",
      "from": "2020-12-01T20:20:07.000Z",
      "to": "2024-01-27T10:18:19.000Z",
      "captures": 5,
      "evidence": "https://web.archive.org/web/20240127101819/https://www.innoventric.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2020-12-01T20:20:07.000Z",
          "to": "2024-01-27T10:18:19.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T17:24:20.950Z",
      "variants": [
        {
          "headline": "World Leader in Cross-Caval Approach for TR Treatment",
          "subhead": "Innoventric introduces a novel transcatheter approach, simplifying the complex challenge of treating tricuspid regurgitation. Our solution is designed with both the physician and patient in mind, offe",
          "observed_at": "2025-01-06T11:11:34.000Z",
          "evidence": "https://web.archive.org/web/20250106111134/https://innoventric.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "World Leader in Cross-Caval Approach for TR Treatment",
          "subhead": "Innoventric introduces a novel transcatheter approach, simplifying the complex challenge of treating tricuspid regurgitation. Our solution is designed with both the physician and patient in mind, offe",
          "observed_at": "2025-07-13T22:58:36.000Z",
          "evidence": "https://web.archive.org/web/20250713225836/https://innoventric.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "World Leader in Cross-Caval Approach for TR Treatment",
          "subhead": "Innoventric introduces a novel transcatheter approach, simplifying the complex challenge of treating tricuspid regurgitation. Our solution is designed with both the physician and patient in mind, offe",
          "observed_at": "2026-07-12T11:35:52.000Z",
          "evidence": "https://web.archive.org/web/20260712113552/https://innoventric.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "World Leader in Cross-Caval Approach for TR Treatment",
          "subhead": "Innoventric introduces a novel transcatheter approach, simplifying the complex challenge of treating tricuspid regurgitation. Our solution is designed with both the physician and patient in mind, offe",
          "observed_at": "2026-11-06T17:24:20.950Z",
          "evidence": "https://innoventric.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "World Leader in Cross-Caval Approach for TR Treatment",
      "subhead": "Innoventric introduces a novel transcatheter approach, simplifying the complex challenge of treating tricuspid regurgitation. Our solution is designed with both the physician and patient in mind, offe",
      "from": "2025-01-06T11:11:34.000Z",
      "to": "2026-11-06T17:24:20.950Z",
      "captures": 4,
      "evidence": "https://innoventric.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2025-01-06T11:11:34.000Z",
          "to": "2026-11-06T17:24:20.950Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-ef651ccd2cc59cf1b9f14a040459053edbab7dc638386885b28e52e910cdffd9:469c66232d6073400145b23dfe1acc95d65fcc48a8db0f52026177142d61abd2:funding:0fece1aedbe4cad8",
      "before_evidence": "https://web.archive.org/web/20240127101819/https://www.innoventric.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “& Events News October 2024 B Round Innoventric Secures $28.5M in Series B Funding!”.",
      "between": {
        "from": "2024-01-27T10:18:19.000Z",
        "to": "2025-01-06T11:11:34.000Z"
      },
      "evidence": "https://web.archive.org/web/20250106111134/https://innoventric.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    },
    {
      "n": 2,
      "id": "page-ef651ccd2cc59cf1b9f14a040459053edbab7dc638386885b28e52e910cdffd9:469c66232d6073400145b23dfe1acc95d65fcc48a8db0f52026177142d61abd2:headline:ae8573701703e4c9",
      "before_evidence": "https://web.archive.org/web/20240127101819/https://www.innoventric.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “A SIMPLE, SAFE, RELIABLE TRANSCATHETER SOLUTION FOR TRICUSPID REGURGITATION” to “World Leader in Cross-Caval Approach for TR Treatment”.",
      "between": {
        "from": "2024-01-27T10:18:19.000Z",
        "to": "2025-01-06T11:11:34.000Z"
      },
      "evidence": "https://web.archive.org/web/20250106111134/https://innoventric.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 3,
      "id": "page-ef651ccd2cc59cf1b9f14a040459053edbab7dc638386885b28e52e910cdffd9:469c66232d6073400145b23dfe1acc95d65fcc48a8db0f52026177142d61abd2:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20240127101819/https://www.innoventric.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2024-01-27T10:18:19.000Z",
        "to": "2025-01-06T11:11:34.000Z"
      },
      "evidence": "https://web.archive.org/web/20250106111134/https://innoventric.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    },
    {
      "n": 4,
      "id": "page-469c66232d6073400145b23dfe1acc95d65fcc48a8db0f52026177142d61abd2:1234a043cd76151e0acffd588f83f7b19e3401c491212961e1e5d45819514a03:funding:0fece1aedbe4cad8",
      "before_evidence": "https://web.archive.org/web/20250106111134/https://innoventric.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “& Events News October 2024 B Round Innoventric Secures $28.5M in Series B Funding!”.",
      "between": {
        "from": "2025-01-06T11:11:34.000Z",
        "to": "2025-07-13T22:58:36.000Z"
      },
      "evidence": "https://web.archive.org/web/20250713225836/https://innoventric.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    },
    {
      "n": 5,
      "id": "page-1234a043cd76151e0acffd588f83f7b19e3401c491212961e1e5d45819514a03:736e4c501cc0d27fef04c178eaaef1eff49d1b6ecd51881ff3a213a1a5fa6523:funding:7f16c37c5fd2b502",
      "before_evidence": "https://web.archive.org/web/20250713225836/https://innoventric.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “B Round Innoventric Secures $28.5M in Series B Funding!”.",
      "between": {
        "from": "2025-07-13T22:58:36.000Z",
        "to": "2026-07-12T11:35:52.000Z"
      },
      "evidence": "https://web.archive.org/web/20260712113552/https://innoventric.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    },
    {
      "n": 6,
      "id": "page-736e4c501cc0d27fef04c178eaaef1eff49d1b6ecd51881ff3a213a1a5fa6523:b2d10476eb660187a608ee52ebdd4522be1354e840db836f505b60e1e153321f:funding:7f16c37c5fd2b502",
      "before_evidence": "https://web.archive.org/web/20260712113552/https://innoventric.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “B Round Innoventric Secures $28.5M in Series B Funding!”.",
      "between": {
        "from": "2026-07-12T11:35:52.000Z",
        "to": "2026-11-06T17:24:20.950Z"
      },
      "evidence": "https://innoventric.com/",
      "evidence_kind": "live_capture",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    }
  ],
  "update": {
    "headline": "Innoventric highlights Series B funding and updated TR treatment focus",
    "summary": "Innoventric’s site emphasizes its Series B funding and positions the company as a leader in cross-caval approaches for TR treatment, alongside adding a careers page. The Series B announcement appears consistently on the homepage across multiple later periods.",
    "points": [
      {
        "text": "Between January 2024 and January 2025, Innoventric announced on its homepage that it “Secures $28.5M in Series B Funding!” and changed its homepage headline to “World Leader in Cross-Caval Approach for TR Treatment”, and added a careers page.",
        "kind": "fact",
        "changes": [
          1,
          2,
          3
        ]
      },
      {
        "text": "Between January 2025 and July 2025, Innoventric continued to announce on its homepage that it “Secures $28.5M in Series B Funding!”.",
        "kind": "fact",
        "changes": [
          4
        ]
      },
      {
        "text": "Between July 2025 and July 2026, the homepage still announced that Innoventric “Secures $28.5M in Series B Funding!”.",
        "kind": "fact",
        "changes": [
          5
        ]
      },
      {
        "text": "Between July 2026 and November 2026, the homepage continued to state that Innoventric “Secures $28.5M in Series B Funding!”.",
        "kind": "fact",
        "changes": [
          6
        ]
      }
    ],
    "written_at": "2026-11-07T16:13:40.645Z",
    "basis": "ai_analysis",
    "model": "gpt-5.1-2025-11-13"
  },
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Innoventric” company record, https://startuphistory.org/c/innoventric.com"
}